Organon

[anonymous]

Can anyone share any insights on this? Management? Culture? Anything would be helpful. Thanks in advance.

 

[anonymous]

Can anyone share any insights on this? Management? Culture? Anything would be helpful. Thanks in advance.

identifies a person or thing
there are quite a few of them. usually two levels above the rep
to supervise or guide
the values accepted or espoused by an individual or group

 

[anonymous]

identifies a person or thing
there are quite a few of them. usually two levels above the rep
to supervise or guide
the values accepted or espoused by an individual or group

Can we get someone that isn't retarded, or is that all Merck has to offer?

 

[anonymous]

The idea of Organon is straightforward. Merck held a lot of assets that might have benefited from a mature brand strategy which is not where Merck wanted to devote it's resources. Hence, these assets were not being maximized to the extent that a smaller hungrier organization might. So, Organon splits off with these "old dogs" and will attempt to make some of them into "cash cows".

Organon will very much focus on business strategies, product marketing, and working with the molecules in hand. Merck will continue with a focus on potentially high value targets coming from innovative R&D.

I think the leadership of Organon has a European heritage, hence I would expect to see them focus on maximizing value in specific markets. Initially, they may "sound" like Merck but will over time drift into a truly distinct organization.

Keep in mind, Express scripts, formerly Medco, was once a part of Merck and is now very much it's own unique company.

 

[anonymous]

The idea of Organon is straightforward. Merck held a lot of assets that might have benefited from a mature brand strategy which is not where Merck wanted to devote it's resources. Hence, these assets were not being maximized to the extent that a smaller hungrier organization might. So, Organon splits off with these "old dogs" and will attempt to make some of them into "cash cows".

Organon will very much focus on business strategies, product marketing, and working with the molecules in hand. Merck will continue with a focus on potentially high value targets coming from innovative R&D.

I think the leadership of Organon has a European heritage, hence I would expect to see them focus on maximizing value in specific markets. Initially, they may "sound" like Merck but will over time drift into a truly distinct organization.

Keep in mind, Express scripts, formerly Medco, was once a part of Merck and is now very much it's own unique company.

Company competing with generics, getting “Merck” pay and benefits for a couple years. Cant last, they wont have the revenue stream to support their cost structure. They are an easy target for a generics company acquisition within a couple years, no others way they survive as is.

 

[anonymous]

The CEO is an arrogant POS and most of the LT are passed overs at Merck. This things a dud. Wish I could short it.

 

[anonymous]

“Organon will very much focus on business strategies, product marketing, and working with the molecules in hand. Merck will continue with a focus on potentially high value targets coming from innovative R&D.“

There hasn’t been a drug discovered by MRL in nearly 20 years. They have never discovered a large molecule drug. It’s all from external acquisitions. Good luck with that business model. Just be sure to sell all your Merck stock before Keytruda goes generic in 2028. This ship is going down!

 

[anonymous]

“Organon will very much focus on business strategies, product marketing, and working with the molecules in hand. Merck will continue with a focus on potentially high value targets coming from innovative R&D.“

There hasn’t been a drug discovered by MRL in nearly 20 years. They have never discovered a large molecule drug. It’s all from external acquisitions. Good luck with that business model. Just be sure to sell all your Merck stock before Keytruda goes generic in 2028. This ship is going down!

This is why we now have Dean Li, to bring in the next Keytruda like compound...

 

[anonymous]

This is why we now have Dean Li, to bring in the next Keytruda like compound...

When the acquired SP they did not even know what Keytruda was, they almost licensed it out. There is no hope, they are incompetent, get out while you can!

 

[anonymous]

Organon is the biggest joke. No one is happy about it and wants to tie themselves down to this crap show. After the two years is up they will probably be bought out or dump reps to stay afloat.